| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.581 | 4.614 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Total Income - EUR | 12.581 | 4.614 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Total Expenses - EUR | 18.029 | 7.435 | 319 | 875 | 221 | 0 | 0 | - | 0 | 0 |
| Gross Profit/Loss - EUR | -5.448 | -2.820 | -319 | -875 | -221 | 0 | 0 | - | 0 | 0 |
| Net Profit/Loss - EUR | -5.825 | -2.908 | -319 | -875 | -221 | 0 | 0 | - | 0 | 0 |
| Employees | 5 | 4 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
Check the financial reports for the company - Angiomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Current Assets | 8.809 | 2.439 | 89 | 17 | 6 | 6 | 6 | - | 0 | 0 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Receivables | 0 | 43 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Cash | 8.809 | 2.396 | 89 | 17 | 6 | 6 | 6 | - | 0 | 0 |
| Shareholders Funds | -7.109 | -9.945 | -10.095 | -10.784 | -10.797 | -10.592 | -10.357 | - | -10.358 | 0 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | - | 40 | 40 |
| Debts | 15.918 | 12.383 | 10.184 | 10.801 | 10.803 | 10.598 | 10.363 | - | 10.358 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4719 - 4719" | |||||||||
| CAEN Financial Year |
8121
|
|||||||||
Comments - Angiomed Srl